Galectin Therapeutics shares owned by Meeder Asset Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Meeder Asset Management
from 13F filings
Historical chart of Meeder Asset Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Galectin Therapeutics by Meeder Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $6.3k | 3.8k | 1.66 |
2023-09-30 | $7.3k | 3.8k | 1.92 |
2023-06-30 | $5.5k | 3.8k | 1.44 |
2023-03-31 | $8.0k | 3.8k | 2.10 |
2022-12-31 | $4.3k | 3.8k | 1.13 |
2022-09-30 | $9.3k | 5.6k | 1.65 |
2022-06-30 | $0 | 6.0k | 0.00 |
2022-03-31 | $0 | 8.0k | 0.00 |
2021-09-30 | $0 | 7.8k | 0.00 |
2021-06-30 | $16k | 4.9k | 3.25 |
2020-03-31 | $0 | 186 | 0.00 |
2019-09-30 | $0 | 19 | 0.00 |